E. Cleiren

发表

A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.

W. Van Hul, J. Horst, W. Balemans, 2005, Bone.

1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus

M. Cummings, B. Devogelaere, F. Pauwels, 2010, Journal of Virology.

Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors

F. Pauwels, O. Nyanguile, E. Cleiren, 2007, Journal of Virology.

TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage

M. Cummings, R. Clayton, B. Devogelaere, 2012, Antimicrobial Agents and Chemotherapy.

Finger loop inhibitors of the HCV NS5b polymerase. Part II. Optimization of tetracyclic indole-based macrocycle leading to the discovery of TMC647055.

M. Cummings, B. Devogelaere, Lili Hu, 2012, Bioorganic & medicinal chemistry letters.

An Autosomal Dominant High Bone Mass Phenotype in Association With Craniosynostosis in an Extended Family Is Caused by an LRP5 Missense Mutation

J. Gille, W. Van Hul, W. Balemans, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's Disease.

Mark E. Schmidt, X. Langlois, J. M. Alonso, 2017, Journal of medicinal chemistry.

Missense Mutations in LRP5 Are Not a Common Cause of Idiopathic Osteoporosis in Adult Men

J. Kaufman, Minrong Ai, A. De Paepe, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase.

M. Cummings, B. Devogelaere, Lili Hu, 2014, Journal of medicinal chemistry.

The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations

Minrong Ai, M. Warman, W. Hul, 2008, Calcified Tissue International.

Novel LRP5 Missense Mutation in a Patient With a High Bone Mass Phenotype Results in Decreased DKK1‐Mediated Inhibition of Wnt Signaling*

J. Devogelaer, W. Van Hul, W. Balemans, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Surface plasmon resonance as a tool to select potent drug candidates for hepatitis C virus NS5B polymerase.

B. Devogelaere, E. Cleiren, K. Fierens, 2013, Methods in molecular biology.

1,5-Benzodiazepine inhibitors of HCV NS5B polymerase.

M. Cummings, Lili Hu, F. Pauwels, 2009, Bioorganic & medicinal chemistry letters.

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

Jens Bollerslev, Tara Renton, Matthew L Warman, 2003, American journal of human genetics.

The ALX4 homeobox gene is mutated in patients with ossification defects of the skull (foramina parietalia permagna, OMIM 168500)

W. Wuyts, T. Homfray, F. Vanhoenacker, 2000, Journal of medical genetics.

Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.

W. Hul, J. Bollerslev, J. Gram, 2001, American journal of human genetics.

Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

W. Hul, J. Bollerslev, M. Whyte, 2001, Human molecular genetics.